| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 486.80M | 432.30M | 397.16M | 341.55M | 281.95M |
| Gross Profit | 0.00 | 169.12M | 143.92M | -16.99M | -19.32M |
| EBITDA | 77.40M | 63.96M | 45.63M | 50.14M | 29.88M |
| Net Income | 500.00K | 3.60M | -12.23M | -18.07M | -43.09M |
Balance Sheet | |||||
| Total Assets | 742.30M | 689.44M | 681.54M | 701.95M | 636.78M |
| Cash, Cash Equivalents and Short-Term Investments | 114.60M | 83.97M | 88.74M | 115.50M | 49.30M |
| Total Debt | 384.10M | 355.63M | 381.96M | 407.10M | 394.66M |
| Total Liabilities | 656.10M | 615.82M | 623.81M | 632.00M | 599.48M |
| Stockholders Equity | 86.20M | 73.62M | 57.73M | 69.96M | 37.28M |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 33.64M | 20.79M | -27.48M | -5.80M |
| Operating Cash Flow | 63.30M | 74.78M | 70.20M | 22.98M | 29.65M |
| Investing Cash Flow | -46.90M | -36.86M | -46.10M | -25.71M | -29.05M |
| Financing Cash Flow | 29.90M | -50.53M | -41.49M | 56.21M | -33.97M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | €139.04B | 19.41 | 51.15% | 0.97% | 12.53% | ― | |
74 Outperform | €106.22M | 20.93 | ― | 3.76% | 2.08% | 28.95% | |
70 Outperform | €47.80B | 28.55 | 22.17% | 1.66% | 7.58% | 61.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | €3.07B | 22.02 | 13.55% | 0.74% | -2.57% | 39.27% | |
48 Neutral | €532.31M | 1,002.64 | -12.90% | ― | 12.61% | -97.71% | |
43 Neutral | €188.29M | -5.83 | -22.05% | ― | 7.21% | 47.92% |